Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salsalate for Insulin Sensitivity in Obese Non-Diabetics
NCT00339833Phase 4Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Mar 2003
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Salsalate with Placebo (2 arms). Primary endpoints: Change in Fasting Plasma Glucose Concentration at 7 days and Change in the Average Serum Insulin Concentration During the Last 40 Min of Clamp at 7 days. Started Mar 2003; status: completed.
02
Drugs
Amigesic
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00339833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00339833.